3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Psoriasis
1
Pruritus
1
Lymphoma, Follicular
1
Interventions
tofacitinib
7
Etanercept
6
Methotrexate
3
Adalimumab
3
secukinumab
2
Nivolumab
2
sotrastaurin
1
sodium luminolate
1
ixekizumab
1
deucravacitinib
1
calcipotriene
1
cabozantinib
1
baricitinib
1
apremilast
1
abrocitinib
1
Vitamin D
1
Vaccines
1
Specimen Handling
1
Saline Solution
1
Platinum Compounds
1
Ipilimumab
1
Herpes Zoster Vaccine
1
Folic Acid
1
Fish Oils
1
Fatty Acids, Omega-3
1
Exercise
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Psoriasis
×
apremilast
×
Clear all
NCT03721172
2024-05-29
ADVANCE
Amgen
Phase 3
Completed
595 enrolled
19 charts